// App-Quantinova.ai

POS0189 (2022) : EFFECT OF ATACICEPT ON RENAL FUNCTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Researchers

Presenter

  • D. Isenberg

Principal Investigators

  • C. J. F. Lin

  • A. Kao

  • A. A. Aydemir

  • C. Gordon

Medical Centers

  • University College London, Division of Medicine, London, United Kingdom

  • Vera Therapeutics, Inc., Clinical Development, Brisbane, United States of America

  • EMD Serono Research & Development Institute, Inc., Translational Innovation Platform (TIP) Immunology, Billerica, United States of America

  • EMD Serono Research and Development Institute, Inc., Billerica, United States of America

  • University of Birmingham Institute of Inflammation and Ageing (IIA), Rheumatology Research Group, Birmingham, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

  • Nephrology

  • Infectious Diseases (ID)

  • Urology

Disease

  • Lupus

  • Chronic kidney disease

  • Glomerulonephritis

  • Renal insufficiency

  • Renal disease

  • Albuminuria

Biomarkers

  • Creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved